Skip to main content
. 2022 May 1;14(1):e2022030. doi: 10.4084/MJHID.2022.030

Table 3.

t-MDS p-MDS. Zeidan et al.14 2017: Proportions of the different karyotypes and risk groups of t-MDS versus p-MDS.

Karyotype
 Poor risk 177 (49%) 272 (18%) <0.005
 Complex (>3 abnormalities) 101 (28%) 162 (11%)
 Del 5/ − 5 106 (30%) 214 (14%)
 Del 7/−7 − 106 (30%) 142 (9%)

IPSS-R

 Very low 30 (9%) 215 (14%) <0.005
 Low 87 (25%) 509 (34%)
 Intermediate 71 (20%) 337 (22%)
 High 71 (20%) 236 (16%)
 Very high 94 (26%) 217 (14%)